Skip to main content
SpringerLink
Log in
Book cover

Sigma Receptors pp 351–370Cite as

σ Receptors in the Immune System: Implications for Potential Therapeutic Intervention - An Overview

  • Chapter

  • 572 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 132:35–86.

    Google Scholar 

  2. Jbilo O, Vidal H, Paul R, De Nys N, Bensaid M, Silve S, Carayon P, Davi D, Galiegue S, Bourrie B, Guillemot JC, Ferrara P, Losion G, Maffrand JP, Le Fur G, Casellas P. Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J Biol Chem 1997, 272:27107–27115.

    Article  PubMed  CAS  Google Scholar 

  3. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996, 229:553–558.

    Article  PubMed  CAS  Google Scholar 

  4. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 1997, 241:35–540.

    Article  Google Scholar 

  5. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 1998, 70:922–931.

    Article  PubMed  CAS  Google Scholar 

  6. Booth RG, Owens CE, Brown RL, Bucholtz EC, Lawler CP, Wyrick SD. Putative sigma, sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand [3H]-(-)(trans-lphenyl-3-aminotetralin. Brain Res. 1999; 837: 95–105.

    Article  PubMed  CAS  Google Scholar 

  7. Gundlach AL, Largent BL, Snyder SH. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxypheny1)-N-(1-propy1)piperidine. J Neurosci 1986, 6: 1757–1770.

    PubMed  CAS  Google Scholar 

  8. Stojilkovic SS, Dufau ML, Catt KJ. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe. Endocrinology 1987, 121:384–394.

    PubMed  CAS  Google Scholar 

  9. Gonzalez-Alvear GM, Thompson-Montgomery D, Deben SE, Werling LL. Functional and binding properties of sigma receptors in rat cerebellum. J Neurochem 1995, 65:2509–2516.

    Article  PubMed  CAS  Google Scholar 

  10. Gonzalez-Alvear GM, Werling LL. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res 1995, 673:61–69.

    Article  PubMed  CAS  Google Scholar 

  11. Wolfe SA Jr, Culp SG, De Souza EB. Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 1989, 124:1160–1172.

    Article  PubMed  CAS  Google Scholar 

  12. Rogers C, Cecyre D, Lemaire S. Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla. Biochem Pharmacol 1989, 38:2467–2472.

    Article  PubMed  CAS  Google Scholar 

  13. Su TP, Wu XZ. Guinea pig vas deferens contains sigma but not phencyclidine receptors. Neurosci Lett 1990, 108:341–345.

    Article  PubMed  CAS  Google Scholar 

  14. Roman F, Pascaud X, Chomette G, Bueno L, Junien JL. Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology 1989, 97:76–82.

    PubMed  CAS  Google Scholar 

  15. Samovilova NN, Nagornaya LV, Vinogradov VA. (+)-[3H]SK & F10,047 binding sites in rat liver. Eur J Pharmacol 1988, 147:259–264.

    Article  PubMed  CAS  Google Scholar 

  16. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 1994, 268:9–18.

    Article  PubMed  CAS  Google Scholar 

  17. De Souza EB, Kulsakdinum C, Wolfe S, Battaglia G, Jaffe JH. Sigma receptors in human perpheral blood leukocytes and rat spleen identification and characterization. Neurosci Branch NIDA Addiction Res Baltimore 1987, 46:1128.

    Google Scholar 

  18. Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 24O:219–221.

    Article  Google Scholar 

  19. Wolfe SA Jr, Kulsakdinun C, Battaglia G, Jaffe JH, De Souza EB. Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther 1988, 247: 1114–1119.

    PubMed  CAS  Google Scholar 

  20. Carr DJ, De Costa BR, Radesca L, Blalock JE. Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system. J Neuroimmunol 1991, 35: 153–166.

    Article  PubMed  CAS  Google Scholar 

  21. Garza HH Jr, Mayo S, Bowen WD, De Costa BR, Carr DJ. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes. J Immunol 1993, 151:4672–4680.

    PubMed  CAS  Google Scholar 

  22. Paul R, Lavastre S, Floutard D, Floutard R, Canat X, Casellas P, Le Fur G, Breliere JC. Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747. J Neuroimmunol 1994, 52: 183–192.

    Article  PubMed  CAS  Google Scholar 

  23. Carayon P, Petitpretre G, Bourrie B, Le Fur G, Casellas P. In vivo effects of a new immunosuppressive sigma ligand, SR 31747, on mouse thymus. Immunopharmacol Immunotoxicol 1996, 18: 179–191.

    PubMed  CAS  Google Scholar 

  24. Wolfe SA Jr, Ha BK, Whitlock BB, Saini P. Differential localization of three distinct binding sites for sigma receptor ligands in rat spleen. J Neuroimmunol 1997, 72:45–58.

    Article  PubMed  CAS  Google Scholar 

  25. Liu Y, Whitlock BB, Pultz JA, Wolfe SA Jr. Sigma-1 receptors modulate functional activity of rat splenocytes. J Neuroimmunol 1995, 59:143–154.

    Article  PubMed  CAS  Google Scholar 

  26. Mei J, Pasternak GW. Molecular cloning and pharmacological characterization of the rat sigma1 receptor. Biochem Pharmacol2001, 62:349–355.

    Article  PubMed  CAS  Google Scholar 

  27. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999, 289:251–260.

    PubMed  CAS  Google Scholar 

  28. Dussossoy D, Carayon P, Belugou S, Feraut D, Bord A, Goubet C, Roque C, Vidal H, Combes T, Loison G, Casellas P. Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level. Eur J Biochem 1999, 263:377–386.

    Article  PubMed  CAS  Google Scholar 

  29. Prasad PD, Li HW, Fei YJ, Ganapathy ME, Fujita T, Plumley LH, Yang-Feng TL, Leibach FH, Ganapathy V. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem 1998, 70:443–451.

    Article  PubMed  CAS  Google Scholar 

  30. Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995, 55:408–413.

    PubMed  CAS  Google Scholar 

  31. Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, Mach RH. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000, 82:1223–1232.

    Article  PubMed  CAS  Google Scholar 

  32. Hellewell SB, Bowen WD. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 1990, 527:244–253.

    Article  PubMed  CAS  Google Scholar 

  33. Bowen WD, Walker JM, de Costa BR, Wu R, Tolentino PJ, Finn D, Rothman RB, Rice KC. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-Nmethyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors. J Pharmacol Exp Ther 1992, 262:32–40.

    PubMed  CAS  Google Scholar 

  34. Su TP. Sigma receptors. Putative links between nervous, endocrine and immune systems. Eur J Biochem 1991, 200:633–642.

    Article  PubMed  CAS  Google Scholar 

  35. Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Arinami T. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998, 257:45–48.

    Article  PubMed  CAS  Google Scholar 

  36. Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS. Autoimmunity in schizophrenia: a review of recent findings. Ann Med 1993, 25:489–496.

    PubMed  CAS  Google Scholar 

  37. Khansari N, Whitten HD and Fudenberg HH. Phencyclidine-induced immunodepression. Science 1984, 225:76–78.

    Article  PubMed  CAS  Google Scholar 

  38. Dornand J, Kamenka JM, Bartegi A, Mani JC. PCP and analogs prevent the proliferative response of T lymphocytes by lowering IL2 production. An effect related to the blockade of mitogen-triggered enhancement of free cytosolic calcium concentration. Biochem Pharmacol 1987, 36:3929–3936.

    Article  PubMed  CAS  Google Scholar 

  39. Carr DJ, Mayo S, Woolley TW, De Costa BR. Immunoregulatory properties of (+)-pentazocine and sigma ligands. Immunology 1992, 77527–531.

    PubMed  CAS  Google Scholar 

  40. Maity R, Mukherjee R, Skolnick P. Stereoselective inhibition of natural killer activity by the sigma ligand (+)-pentazocine. J Neuroimmunol 1996, 70:7–13.

    Article  PubMed  CAS  Google Scholar 

  41. Itzhak Y. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 1989, 36 512–517.

    PubMed  CAS  Google Scholar 

  42. Hayashi T, Maurice T, Su TP. Ca2+ signaling via sigma,-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration. J Pharmacol Exp Ther 2000, 293:788–798.

    PubMed  CAS  Google Scholar 

  43. Hayashi T, Su TP. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001, 98:491–496.

    Article  PubMed  CAS  Google Scholar 

  44. Cahalan MD, Wulff H, Chandy KG. Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol2001, 21:235–252.

    Article  PubMed  CAS  Google Scholar 

  45. Mahaut-Smith MP, Mason MJ. ca2+-activated K+ channels in rat thymic lymphocytes: activation by concanavalin A. J Physiol 1991, 439513–528.

    PubMed  CAS  Google Scholar 

  46. Sharma B. Inhibition of the generation of cytotoxic lymphocytes by potassium ion channel blockers. Immunology 1988, 65: 101–105.

    PubMed  CAS  Google Scholar 

  47. Aydar E, Palmer CP, Klyachko VA, Jackson MB. The sigma receptor as a ligandregulated auxiliary potassium channel subunit. Neuron 2002, 34:399–410.

    Article  PubMed  CAS  Google Scholar 

  48. Wilke RA, Mehta RP, Lupardus PJ, Chen Y, Ruoho AE, Jackson MB. Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells. J Biol Chem 1999, 274:18387–18392.

    Article  PubMed  CAS  Google Scholar 

  49. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D Jr, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 1997, 158:5120–5128.

    PubMed  CAS  Google Scholar 

  50. Bourrie B, Bribes E, De Nys N, Esclangon M, Garcia L, Galiegue S, Lair P, Paul R, Thomas C, Vernieres JC, Casellas P. SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties. Eur J Pharmacol2002, 456: 123–131.

    Article  PubMed  CAS  Google Scholar 

  51. Berthois Y, Bourrie B, Galiegue S, Vidal H, Carayon P, Martin PM, Casellas P. SR3 1747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo. Br J Cancer 2003, 88:438–446.

    Article  PubMed  CAS  Google Scholar 

  52. Silve S, Dupuy PH, Labit-Lebouteiller C, Kaghad M, Chalon P, Rahier A, Taton M, Lupker J, Shire D, Loison G. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits deltabdelta7 sterol isomerase activity in yeast. J Biol Chem 1996, 271:22434–22440.

    Article  PubMed  CAS  Google Scholar 

  53. Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem 1995, 270:7551–7557.

    Article  PubMed  CAS  Google Scholar 

  54. Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997, 18:67–70.

    Article  PubMed  CAS  Google Scholar 

  55. Paul R, Silve S, De Nys N, Dupuy PH, Bouteiller CL, Rosenfeld J, Ferrara P, Le Fur G, Casellas P, Loison G. Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian A8d7 sterol isomerase. J Pharmacol Exp Ther 1998, 285:1296–1302.

    PubMed  CAS  Google Scholar 

  56. Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P, Lupker J. Antiproliferative effects of SR 3 1747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. Eur J Biochem 1998, 256:342–349.

    Article  PubMed  CAS  Google Scholar 

  57. Casellas P, Bourrie B, Canat X, Carayon P, Buisson I, Paul R, Breliere JC, Le Fur G. Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses. J Neuroimmunol 1994, 52: 193–203.

    Article  PubMed  CAS  Google Scholar 

  58. Derocq JM, Bourrie B, Segui M, Le Fur G, Casellas P. In vivo inhibition of endotoxininduced pro-inflammatory cytokines production by the sigma ligand SR 31747. J Pharmacol Exp Ther 1995, 272:224–230.

    PubMed  CAS  Google Scholar 

  59. Bourrie B, Bouaboula M, Benoit JM, Derocq JM, Esclangon M, Le Fur G, Casellas P. Enhancement of endotoxin′4nduced interleukin-10 production by SR 31747A, a sigma ligand. Eur J Immunol 1995, 25:2882–2887.

    PubMed  CAS  Google Scholar 

  60. Bourrie B, Benoit JM, Derocq JM, Esclangon M, Thomas C, Le Fur G, Casellas P. A sigma ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice. Immunology 1996, 88:389–393.

    Article  PubMed  CAS  Google Scholar 

  61. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994, 179: 1517–1527.

    Article  PubMed  CAS  Google Scholar 

  62. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Ann Rev Immunol2001, 19: 163–196.

    Article  CAS  Google Scholar 

  63. Cinato E, Peleraux A, Silve S, Galiegue S, Dhers C, Picard C, Jbilo 0, Loison G, Casellas P. A DNA microarray-based approach to elucidate the effects of the immunosuppressant SR 31747A on gene expression in Saccharomyces cerevisiae. Gene Expr 2002, 10:213–230.

    PubMed  CAS  Google Scholar 

  64. Vidal H, Mondesert G, Galikgue S, Carrikre D, Dupuy PH, Carayon P, Combes T, Bribes E, Simony-Lafontaine J, Kramar A, Loison, Casellas P. Identification and pharmacological characterization of SRBP-2 — a novel SR 31747A-binding protein. Cancer Res 2003, 63:4809–18.

    PubMed  CAS  Google Scholar 

  65. Ferrini JB, Jbilo 0, Pelereau A, Combes T, Vidal H, Galiegue S, Casellas P. Transcriptomic classification of antitumor agents: application to the analysis of the antitumoral effect of SR 3 1747A. Gene Expr 2003, 11:125–39.

    PubMed  CAS  Google Scholar 

  66. Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 2002, 62:313–322

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sanofi-Aventis, 371 rue du Professeur Joseph Blayac, F-34184, Montpellier cedex 04, France

    Sylvaine Galiegue, Hubert Vidal & Dr. Pierre Casellas

Authors
  1. Sylvaine Galiegue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hubert Vidal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. Pierre Casellas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre Casellas .

Editor information

Editors and Affiliations

  1. National Institute on Drug Abuse, Bethesda, MD

    Tsung-Ping Su

  2. University of Mississippi, University, MS

    Rae R. Matsumoto

  3. Brown University, Providence, RI

    Wayne D. Bowen

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Galiegue, S., Vidal, H., Casellas, P. (2007). σ Receptors in the Immune System: Implications for Potential Therapeutic Intervention - An Overview. In: Su, TP., Matsumoto, R.R., Bowen, W.D. (eds) Sigma Receptors. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36514-5_17

Download citation

Publish with us

Policies and ethics

Search

Navigation